Skip to content
Home/Companies/MedTech/ArgusEye

ArgusEye

MedTech·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns ArgusEye?

ArgusEye is a Swedish MedTech company, currently owned by Eir Ventures since 2021.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Eir Ventures
Investor
Eir Ventures
Eir Ventures I · 2020 · Life Sciences VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from Eir Ventures I

Other portfolio companies in the same fund.

Moleculent
Active
BiotechSweden· 2024
Purpose Pharma
Active
PharmaSweden· 2024
Dania Tx
Active
BiotechDenmark· 2023
GutCRINE
Active
BiotechDenmark· 2023
RAPP
Active
HealthTechSweden· 2023
Scenic Biotech
Scenic Biotech
Active
BiotechNetherlands· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns ArgusEye?

ArgusEye is currently owned by Eir Ventures, through Eir Ventures I, since 2021.

When did Eir Ventures acquire ArgusEye?

Eir Ventures acquired ArgusEye in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue